Overview A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Doses of AZD9567. Status: Completed Trial end date: 2017-09-11 Target enrollment: Participant gender: Summary A study to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of multiple ascending doses of AZD9567. Phase: Phase 1 Details Lead Sponsor: AstraZenecaTreatments: MethylprednisoloneMethylprednisolone AcetateMethylprednisolone HemisuccinatePrednisolonePrednisolone acetatePrednisolone hemisuccinatePrednisolone phosphate